ResearcherSheba Medical CenterNo recent work listed

Yael Laitman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7338-0233; OpenAlex author ID A5107839689. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer. Co-author DOI 10.1007/s10689-019-00157-1 ↗
The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer. Co-author DOI 10.1007/s10689-011-9507-1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eitan Friedman · 2 shared papers, 2012–2020 · strength 0.20
- Paper De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer. DOI 10.1007/s10689-019-00157-1 ↗
- Paper The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cance… DOI 10.1007/s10689-011-9507-1 ↗
Rinat Bernstein‐Molho · 1 shared paper, 2020 · strength 0.16
- Paper De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer. DOI 10.1007/s10689-019-00157-1 ↗
Talia Golan · 1 shared paper, 2012 · strength 0.04
- Paper The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cance… DOI 10.1007/s10689-011-9507-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.